CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		9 Months Ended
		Oct. 29, 2021	Oct. 30, 2020
Cash flows from operating activities:
Net income		$ 5,706	$ 2,162
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		3,721	4,017
Stock-based compensation expense		1,406	1,219
Deferred income taxes		(450)	(219)
Other, net (a)	[1]	(4,312)	(322)
Changes in assets and liabilities, net of effects from acquisitions and dispositions:
Accounts receivable		(1,587)	885
Financing receivables		234	(624)
Inventories		(2,063)	(198)
Other assets and liabilities		(1,624)	(2,175)
Accounts payable		5,149	(216)
Deferred revenue		1,034	1,001
Change in cash from operating activities		7,214	5,530
Cash flows from investing activities:
Purchases of investments		(320)	(296)
Maturities and sales of investments		454	98
Capital expenditures and capitalized software development costs		(2,056)	(1,584)
Acquisition of businesses and assets, net		(16)	(405)
Divestitures of businesses and assets, net		3,957	2,187
Other		34	26
Change in cash from investing activities		2,053	26
Cash flows from financing activities:
Proceeds from the issuance of common stock		326	389
Repurchases of parent common stock		(35)	(240)
Repurchases of subsidiary common stock		(1,174)	(890)
Proceeds from debt		13,037	14,772
Repayments of debt		(13,069)	(17,244)
Other		(113)	(270)
Change in cash from financing activities		(1,028)	(3,483)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash		(54)	(67)
Change in cash, cash equivalents, and restricted cash		8,185	2,006
Cash, cash equivalents, and restricted cash at beginning of the period		15,184	10,151
Cash, cash equivalents, and restricted cash at end of the period		$ 23,369	$ 12,157

[1] During the nine months ended October 29, 2021, other, net, includes $4.0 billion pre-tax gain on the sale of Boomi.